Moderna says its RSV vaccine for older adults is 84% effective at preventing serious illness
(NEW YORK) -- Moderna's respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at preventing serious illness, according to data from a late-stage trial published Tuesday.Adult patients in the clinical trial appeared to tolerate the vaccine well and there were... Read More.